The objective of this study was to determine the effectiveness of Neotrofin in the treatment of iron deficiency anemia in pregnant women.
The study was performed in a longitudinal design, single-center, randomized, open-label, hemoglobin value was less than 110 g / L in the detection of pregnancy, attended in consultation on Nutrition at the Maternal and Child Teaching Hospital (Hijas de Galicia) 10 de Octubre. The estimated sample size was 250 patients and the inclusion of these pregnant in the study was conducted randomly, administering doses of three tablets per day of Neotrofin to recovery of hematological parameters.
In the study demonstrate the high prevalence of anemia in the area, more than 60%. It was found that 56% of patients Neotrofin is effective in improving hemoglobin levels with a number needed to treat of 2. In addition Neotrofin guaranteed at a high percent the restoring of iron stores as ferritin.
It can be concluded that the use of Neotrofin as antianemic in pregnant has a high efficiency by making it possible to use as antianemic in this population.